You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Doxorubicin

Showing 1 - 25 of 2,696
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)

Not yet recruiting
  • Advanced Soft-tissue Sarcoma
  • LB-100 plus Doxorrubicin
  • Doxorubicin
  • (no location specified)
Apr 11, 2023

Metastatic Leiomyosarcoma, Metastatic Sarcoma, Metastatic Soft Tissue Sarcoma Trial (Computed Tomography, Magnetic Resonance

Not yet recruiting
  • Metastatic Leiomyosarcoma
  • +5 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Feb 2, 2023

Breast Cancer With Liposomal Doxorubicin Regimen

Recruiting
  • Breast Cancer
  • +4 more
  • Liposomal doxorubicin containing regimen
  • Hangzhou, Zhejiang, China
    Second Affiliate Hospital of Zhejiang University
Feb 7, 2023

Solid Tumor, KRAS Mutation-Related Tumors Trial in Washington (NEROFE, Doxorubicin)

Recruiting
  • Solid Tumor
  • KRAS Mutation-Related Tumors
  • Washington, District of Columbia
    Georgetown Lombardi Comprehensive Cancer Center
Jan 23, 2023

Relapsed Sarcomas Trial in Cleveland (Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil))

Not yet recruiting
  • Relapsed Sarcomas
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Apr 18, 2022

Basal Cell Carcinoma Trial in Aventura (Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing

Terminated
Has Results
  • Basal Cell Carcinoma
  • Placebo-containing MNA
  • +4 more
  • Aventura, Florida
    The Center for Clinical and Cosmetic Research
Aug 16, 2022

Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue Sarcoma Trial in Aurora (doxorubicin with AGEN1884 and AGEN2034)

Recruiting
  • Metastatic Soft Tissue Sarcoma
  • Advanced Soft Tissue Sarcoma
  • doxorubicin with AGEN1884 and AGEN2034
  • Aurora, Colorado
    University of Colorado Hospital
Jan 4, 2023

Metastatic Adult Soft Tissue Sarcoma, Recurrent Adult Soft Tissue Sarcoma Trial in Hannover (Durvalumab and Tremelimumab,

Completed
  • Metastatic Adult Soft Tissue Sarcoma
  • Recurrent Adult Soft Tissue Sarcoma
  • Durvalumab and Tremelimumab
  • Doxorubicin
  • Hannover, Germany
    Medizinische Hochschule Hannover
Jan 18, 2023

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Desmoid Tumor Trial in GuangZhou (Liposome doxorubicin, Saline Solution)

Recruiting
  • Desmoid Tumor
  • Liposome doxorubicin
  • Saline Solution
  • GuangZhou, Guangdong, China
    Sun Yat-sen University cancer center
Sep 29, 2022

Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma Trial in Pittsburgh (Microneedle Array Doxorubicin

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Skin Cancers - Squamous Cell Carcinoma
  • Microneedle Array Doxorubicin (MNA-D)
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Medical Center
Nov 28, 2022

Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

Active, not recruiting
  • Soft Tissue Sarcoma
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 25, 2023

Breast Cancer Trial in Seoul (Extracorporeal shock waves)

Recruiting
  • Breast Cancer
  • Extracorporeal shock waves
  • Seoul, Yangcheon Gu, Korea, Republic of
    Kiwhan Kim
Oct 25, 2022

Kaposi Sarcoma, HIV-1-infection Trial (Pegylated liposomal doxorubicin, Paclitaxel)

Not yet recruiting
  • Kaposi Sarcoma
  • HIV-1-infection
  • (no location specified)
Jan 20, 2023

Colon Cancer Liver Metastasis Trial in United States (Lyso-Thermosensitive Liposomal Doxorubicin, 5% Dextrose Solution,

Terminated
Has Results
  • Colon Cancer Liver Metastasis
  • Lyso-Thermosensitive Liposomal Doxorubicin
  • +2 more
  • Los Angeles, California
  • +3 more
Sep 15, 2022

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Advanced Sarcoma, Metastatic Sarcoma, Soft Tissue Sarcoma Trial (YH001, Envafolimab, Doxorubicin)

Recruiting
  • Advanced Sarcoma
  • +2 more
  • Santa Monica, California
    Sarcoma Oncology Center
Dec 5, 2022

Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

Recruiting
  • Metastatic Kidney Medullary Carcinoma
  • +4 more
  • Doxorubicin
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Soft Tissue Sarcoma, Adult, Soft Tissue Sarcoma, Child Trial in Charlotte (Pembrolizumab, Doxorubicin)

Active, not recruiting
  • Soft Tissue Sarcoma, Adult
  • Soft Tissue Sarcoma, Child
  • Charlotte, North Carolina
    Levine Cancer Institute
Sep 29, 2022

Advanced Malignant Tumors Trial in Shanghai (doxorubicin HCl liposome injection)

Recruiting
  • Advanced Malignant Tumors
  • doxorubicin hydrochloride liposome injection
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 28, 2022

Breast Cancer Trial in New York (Coenzyme Q10, Coenzyme Q10 Placebo)

Completed
  • Breast Cancer
  • New York, New York
    Columbia University Medical Center
Oct 13, 2022

Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))

Recruiting
  • Cutaneous T Cell Lymphoma
  • Micro needle array-Doxorubicin (MNA-D)
  • Pittsburgh, Pennsylvania
    University Of Pittsburgh Medical Center
Jun 2, 2022

Brain Tumor Trial in Washington (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Exablate
  • Doxorubicin
  • Washington, District of Columbia
    Children's National Medical Center
Jan 4, 2023

Brain Tumor Trial in Toronto (Exablate, Doxorubicin)

Recruiting
  • Brain Tumor
  • Exablate
  • Doxorubicin
  • Toronto, Ontario, Canada
    Sunnybrook Research Institute
Jan 5, 2023

Mitochondrial dysfUnction:Key Player in Doxorubicin-induced

Not yet recruiting
  • Doxorubicin Induced Cardiomyopathy
  • +3 more
  • 31-MRS at 7 Tesla (T)
  • Utrecht, Netherlands
  • +1 more
Feb 7, 2023